021-51111890
购物车（）
sales@molnova.cn
β-D-Glucan
CAS No. 9041-22-9
β-D-Glucan ( —— )
产品货号. M36586 CAS No. 9041-22-9
β-D-glucan 是一种天然的不易消化的多糖，具有很高的生物相容性，可被识别受体，如 Dectin-1 和 Toll 样受体选择性识别，并容易被鼠或人巨噬细胞内化。β-D-glucan 是益生菌的肠道输送载体。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥244 | 有现货 |
|
| 10MG | ￥392 | 有现货 |
|
| 25MG | ￥617 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称β-D-Glucan
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述β-D-glucan 是一种天然的不易消化的多糖，具有很高的生物相容性，可被识别受体，如 Dectin-1 和 Toll 样受体选择性识别，并容易被鼠或人巨噬细胞内化。β-D-glucan 是益生菌的肠道输送载体。
-
产品描述β-D-glucan is a natural non-digestible polysaccharide and high biocompatibility that can be selectively recognized by recognition receptors such as Dectin-1 and Toll-like receptors as well as being easily internalized by murine or human macrophages, which is likely to attribute to a target delivery. β-d-glucan is an enteric delivery vehicle for probiotics.
-
体外实验β-D-glucan dissolved in DMSO but not water inhibits MCF-7 cell proliferation in a concentration-dependent manner as measured by BrdU incorporation with an IC50 of ～164μg/mL. β-D-glucan dissolved in DMSO inhibits tamoxifen/endocrine-resistant LCC9 and LY2 cell proliferation with IC50 values of 4.6 and 24.2 μg/mL, respectively.
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number9041-22-9
-
分子量
-
分子式——
-
纯度>98% (HPLC)
-
溶解度In Vitro:?1M NaOH 中的溶解度 : 50 mg/mL (超声助溶 碱性条件溶解 (NaOH 调节，pH≈11)
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Su Y, et al. pH-sensitive PEG-coated hyper-branched β-d-glucan derivative as carrier for CpG oligodeoxynucleotide delivery. Carbohydr Polym. 2020;246:116621. ?
产品手册
关联产品
-
ADP - Ribosylation F...
ADP - Ribosylation Factor 6, ARF6 (2 - 13)
-
DPPS
12-Dipalmitoyl-sn-glycero-3-PS sodium salt 是一种阴离子二酰基磷脂，是细胞膜中的一种脂质成分。12-Dipalmitoyl-sn-glycero-3-PS sodium salt 可用于制备阳离子囊泡和脂质体。
-
[Ala286]-Calmodulin-...
[Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) is a modified fragment of calcium/calmodulin-dependent protein kinase II that contains the active domain of CaMKII and has an alanine substitution at position 286. [Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) can be used to develop more potent CaMKII inhibitors.
